v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (12,622) $ (15,329)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 647 443
Amortization of debt (premium) and issuance costs (381) 46
Amortization of right-of-use asset 39 570
Change in fair value of convertible debt carried at fair value 835 0
Loss on disposal of fixed and intangible assets 0 55
Gain on debt extinguishment (71) 0
Stock-based compensation expense 2,024 3,178
Issuance of convertible notes for legal services 384 0
Changes in operating assets and liabilities:    
Accounts receivable 679 (15)
Prepaids and other current assets (2,165) 3,674
Insurance receivable 308 (308)
Other non-current assets 495 31
Accounts payable 1,480 805
Accrued liabilities 379 451
Accrued interest 270 0
Other current liabilities 502 (4)
Contract liabilities 900 115
Operating lease liability (302) (625)
Litigation settlement contingency (308) 526
Other non-current liabilities (515) 13
Net cash used in operating activities (7,422) (6,374)
Cash flows from investing activities:    
Purchases of intangible assets 0 (40)
Net cash used in investing activities 0 (40)
Cash flows from financing activities:    
Proceeds from issuance of convertible notes 178 0
Payment of convertible notes (672) 0
Proceeds from issuance of loan payable 0 350
Principal payments on loan payable 0 (2,319)
Payment of debt issuance costs (78) 0
Proceeds from issuance of warrants 572 0
Proceeds from exercise of warrants 2,068 0
Payments for issuance costs related to exercise of warrants (204) 0
Repurchase of Section 16 Officer shares for tax coverage exchange (1) (3)
Payment of deferred offering costs (283) 0
Proceeds from issuance of common stock and related warrants 5,000 8,000
Payments for issuance costs related to common stock and related warrants (598) (829)
Net cash provided by financing activities 5,982 5,199
Decrease in cash and cash equivalents (1,440) (1,215)
Cash and cash equivalents, beginning of period 1,572 2,492
Cash and cash equivalents, end of period $ 132 $ 1,277